Paraneoplastic rapidly progressive cerebellar syndrome (RPCS) associated with anti-Yo antibodies is classically described in breast or gynecological neoplasms, and is more frequent when the oncological disease is active. The gene discussed is CDR2; the disease is female reproductive system neoplasm.